Clinical Lab. Investigations

Clinical Lab. Investigations Interested with Laboratory Medicine Investigations

26/02/2022

ترقبوا الجديد في تحقيقات المختبرات الطبيه بمحاضرات فيديويه باللغتين الانكليزيه والعربيه.
ارجو عمل مشاركه للصفحه .
تحياتي .

Who know answer this Case  :A 28-year-old man comes to the physician because of a 1-year history of pain with urination ...
29/01/2022

Who know answer this Case :

A 28-year-old man comes to the physician because of a 1-year history of pain with urination that has increased in severity
during the past month. He also has had episodes of blood in his urine during the past 5 years. He lived in sub-Saharan Africa
until he came to the USA 6 months ago for graduate school. His temperature is 38°C (100.4°F), pulse is 80/min, respirations
are 16/min, and blood pressure is 110/84 mm Hg. Physical examination shows suprapubic tenderness. Imaging studies show bilateral hydroureter and hydronephrosis and foci of calcification in the region of the bladder. A biopsy specimen of the bladder shows marked chronic inflammation with fibrosis and scattered granulomas. Which of the following
best explains the biopsy findings?

We now offer even more verified real‑time PCR assays to build your own custom Applied Biosystems™ TaqMan® SARS‑CoV‑2 Mut...
29/01/2022

We now offer even more verified real‑time PCR assays to build your own custom Applied Biosystems™ TaqMan® SARS‑CoV‑2 Mutation Panel, including the Delta Plus and Omicron variants. Get the answers you need today, while preparing for what’s to come. This scalable solution lets you run a few or hundreds of samples to identify one or many mutations—all on your current real‑time PCR instrumentation.

Mutation WHO label Associated variants Assay ID Cat. No.
375 reactions Cat. No.
1,250 reactions
S.Y145H.TAC.CAC Delta + AY.4.2 CVFVKJ7 A49785 A49786
S.G339D.GGT_GAG Omicron B.1.1.529 CV47VRX A49785 A49786
S.Q493R.CAA_CGA Omicron B.1.1.529 CVH49P2 A49785 A49786

Infographic  structure of the Influenza Virus
29/01/2022

Infographic structure of the Influenza Virus

Insulin's effect on dopamine may drive obesity:Insulin's effects on dopamine levels could be a key factor in the brain's...
29/01/2022

Insulin's effect on dopamine may drive obesity:

Insulin's effects on dopamine levels could be a key factor in the brain's regulation of glucose metabolism and eating habits, according to a study in the Journal of Clinical Endocrinology & Metabolism. "It has also been shown that obesity leads to changes in the signaling of the brain that have a negative effect on the glucose metabolism in the whole body," first author Stephanie Kullmann sai

IBD patients using specific carbohydrate diet report symptom improvement:Patients with inflammatory bowel disease report...
29/01/2022

IBD patients using specific carbohydrate diet report symptom improvement:

Patients with inflammatory bowel disease reported improvement in symptoms using a personalized specific carbohydrate diet, according to a presenter at the Crohn’s and Colitis Congress.

Ali Arjomand, PhD, director of Modulla Health in Washington, and colleagues developed My SCD Protocol, a customizable plan for patients with IBD, based on the specific carbohydrate diet (SCD). The digital protocol provides educational resources, self-assessment tools and instructions for patients interested in using the SCD.

“The real key is not to go too fast with the introduction of ingredients and also not to go too slow,” Arjomand said during the presentation. “So, I base that on patient-reported self-monitoring on how they're doing and how they're responding to the ingredients. Essentially that's where they progress until they reach their individual goals. This is very customized. That's why it's called My SCD Protocol. Every patient does it their way, according to their needs. “

Arjomand and colleagues evaluated 87 IBD patients who implemented the My SCD Protocol, which includes 304 SCD ingredients and 164 stage-specific recipes. Ingredients were presented in four stages — elimination, reintroduction, maintenance and expansion — to help patients expand tolerable ingredients. pPatients used a HIPAA-compliant mobile app to self-report symptoms, meals and progress, which could be assessed by the patient’s care team.

Investigators observed clinical and biochemical responses in both adult and pediatric IBD patients on the SCD and noted improvements in patients’ self-reported symptoms.. From baseline to 21 days of intervention, the greatest improvements were reported in vomiting (7% vs. 22%), belching (7% vs. 39%), bloating/pressure (15% vs. 38%) and flatulence (18% vs. 37%).

“It's a very brief intervention but [patients are] seeing marked response in some of their observable interventions and symptoms,” Arjomand said. “This is critical, because when patients do see improvement, or disappearance of symptoms, they become really committed and adhere to the diet and stay for longer haul. So, the goal here is to show some immediate response change the quality of life and show improvements.”

The next steps, Arjomand explained, include f***l calprotectin measurements, objective markers, eat-to-target, connect with electronic health records and to bring My SCD Protocol to other existing IBD centers.

Research: Pediatric T1D cases rose during the pandemic:A study in JAMA Pediatrics found that the number of children diag...
29/01/2022

Research: Pediatric T1D cases rose during the pandemic:

A study in JAMA Pediatrics found that the number of children diagnosed with type 1 diabetes during the COVID-19 pandemic was significantly higher than in previous years, and there were also more cases where children initially presented with pediatric diabetic ketoacidosis during the one-year pandemic period. However, there was no significant difference in the percentage of children that had to be admitted to pediatric intensive care, and there were also no differences in average age at presentation, A1C levels or body mass index z-score.

(( Resistance-guided therapy is the concept of using diagnostics to not only identify the pathogen that is causing the d...
29/01/2022

(( Resistance-guided therapy is the concept of using diagnostics to not only identify the pathogen that is causing the disease, but to also provide clinicians with information to guide the best patient treatment ))
Madeline O’Donoghue
Global Marketing Director

Among women with obesity and unexplained infertility, weight loss before infertility treatment did not increase the like...
29/01/2022

Among women with obesity and unexplained infertility, weight loss before infertility treatment did not increase the likelihood of having a healthy live birth, according to findings published in PLoS Medicine.

However, researchers said that weight loss may confer other health benefits for women with obesity who are trying to conceive. Their study revealed improvements in metabolic health, including a decrease in the incidence of metabolic syndrome, among women who were enrolled in an intensive lifestyle intervention compared with those who were enrolled in a standard exercise intervention.

Incidence of healthy live births among women with obesity and unexplained infertility

“We can achieve significant weight loss and improvement in cardiometabolic health through an intensive lifestyle intervention in women who are obese with unexplained infertility in a reasonably short time period of 16 weeks,” Richard S. Legro, MD, FACOG, a professor in the department of obstetrics and gynecology and public health sciences at Penn State University College of Medicine, and colleagues wrote.

Weight loss over a short time period “improves multiple metabolic markers associated with long-term risk for diabetes and heart disease,” Legro told Healio.

Richard S. Legro
In an open-label, randomized controlled trial that was conducted from July 2015 to July 2018, Legro and colleagues randomly assigned 379 women with obesity (BMI 30 kg/m²) and unexplained infertility into a 1:1 ratio to participate in the intensive lifestyle intervention or standard exercise intervention for 16 weeks. The mean age of the women was about 32 years. Following the intervention, the women received infertility therapy consisting of three cycles of ovarian stimulation/intrauterine insemination.

In the intensive intervention group, 188 women underwent increased physical activity and targeted weight loss (7%) through meal replacements and orlistat administration. In the standard exercise group, 191 women underwent increased physical activity alone without targeted weight loss. However, during the study period, 40 women dropped out of the standard exercise group and 31 women dropped out of the intensive intervention group.

Metabolic improvements with weight loss
Overall, there was no significant difference in the incidence of healthy live births in the standard exercise group (15.2%) and the intensive intervention group (12.2%; RR = 0.81; 95% CI, 0.48-1.34), according to the researchers. Women receiving the intensive intervention experienced significant weight loss compared with the standard group (6.6% vs 0.3%; P < .001). These women experienced improvements in metabolic and reproductive health parameters, including decreased BP, waist circumference, total testosterone, insulin, glycohemoglobin, leptin, high-sensitivity C-reactive protein and triglycerides and increased s*x hormone–binding globulin and adiponectin levels. Legro and colleagues also observed that the incidence of metabolic syndrome decreased significantly among women in the intensive intervention group (P = .003), yet gastrointestinal adverse events were more common. Also, there was an insignificant increase in miscarriages during the first trimester in the intensive intervention group (33.3%) compared with the standard care group (23.7%; 95% CI, 0.79-2.5).

Additional research needed
“Our findings directly impact current standards of clinical care, where women who are obese with unexplained infertility are to our knowledge routinely counseled to lose weight prior to initiation of infertility treatment,” Legro and colleagues wrote.

Based on the findings, “patients may forgo a long-term benefit of weight loss if they see no short-term benefit in achieving it, and actually may experience short-term harm through increased pregnancy loss with weight loss or just a waste of time in pursuing weight loss while the sands of the fertility hourglass are running out,” Legro said.

He advised that, until research can prove demonstrable benefits related to fertility, physicians “should stop telling women” with obesity and infertility to lose weight prior to pregnancy.

References:
Legro RS, et al. PLoS Med. 2022;doi:10.1371/journal.pmed.1003883.

Analysis: Ginger tied to lower blood glucose: A review and analysis in the journal Complementary Therapies in Medicine f...
29/01/2022

Analysis: Ginger tied to lower blood glucose:

A review and analysis in the journal Complementary Therapies in Medicine found that ginger supplementation received by people with type 2 diabetes was associated with decreases in fasting blood glucose, A1C and systolic and diastolic blood pressure levels. Ginger supplementation did not result in significant change in lipid profile

Address

Health Ministry Street
Baghdad
100001

Telephone

+9647710313115

Website

Alerts

Be the first to know and let us send you an email when Clinical Lab. Investigations posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Clinical Lab. Investigations:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category